- Management of psoriasis in adults and children by IL-17 A inhibitor secukinumab biologic therapy2020 | Publication without faculty affiliation
- IL-17 inhibitors in psoriasis treatment2022 | Third Faculty of Medicine
- Inhibition of IL-17 - a new approach in the biological treatment of spondyloarthritides2017 | First Faculty of Medicine
- Management of psoriatic disease with anti IL-17 and anti-IL-23 monoclonal antibodies2022 | Faculty of Medicine in Hradec Králové
- Ideal patient for IL-17 inhibitors treatment2022 | First Faculty of Medicine
- Long-term outcomes of ixekizumab treatment in patients with axial spondyloarthritis2023 | First Faculty of Medicine
- Systematic analysis of the IL-17 receptor signalosome reveals a robust regulatory feedback loop2020 | First Faculty of Medicine
- IL-17 driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileum2023 | Faculty of Science, Second Faculty of Medicine
- ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis2018 | Central Library of Charles University
- A Low-Molecular-Weight Dialysable Leukocyte Extract Selectively Enhances Development of CD4+RORγt+ T cells and IL-17 production2014 | Faculty of Science
- Influencing interkeukin 17A in biological therapy of psoriatis and psoriatic arthritis2019 | Faculty of Medicine in Hradec Králové
- Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Central Library of Charles University
- Terapie komplikované psoriatické artritidy inhibitorem IL-172023 | Faculty of Medicine in Hradec Králové
- Immunopathological inflammation in patients with psoriasis is effectively reduced by bimekizumab treatment targeting simultaneously IL-17A and IL-17F2023 | Faculty of Medicine in Hradec Králové
- Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?2023 | Second Faculty of Medicine
- Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study2021 | Third Faculty of Medicine
- CMTM4 is a subunit of the IL-17 receptor and mediates autoimmune pathology2022 | First Faculty of Medicine
- Current treatment options for spondyloarthritits2018 | First Faculty of Medicine
- Highly active form of psoriatic arthritis on top of pemphigus vulgaris and its successful treatment with secukinumab2018 | First Faculty of Medicine
- Immmunologic mechanisms in reccurent aphtaePublication without faculty affiliation
- Interleukin-17A Gene Variability in Patients with Type 1 Diabetes Mellitus and Chronic Periodontitis: Its Correlation with IL-17 Levels and the Occurrence of Periodontopathic Bacteria2016 | Publication without faculty affiliation
- Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP)2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Central Library of Charles University
- Invasive aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate and corticosteroids for psoriasis and psoriatic arthritis2022 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Current Approach to Modern Treatment of Psoriasis - Updated Guidelines of ČDS JEP for Targeted Treatment of Severe Chronic Psoriasis2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Drug Survival of Interleukin (IL)-17 and IL-23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi-country, Multicentric Cohort Study2022 | Third Faculty of Medicine
- Advances in biological therapy for psoriasis2017 | First Faculty of Medicine
- Stratification of treatment in axial spondyloarthritis2019 | First Faculty of Medicine
- Neutrophils mediate Th17 promotion in COVID-19 patients2021 | First Faculty of Medicine, Second Faculty of Medicine
- p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+T-cells2017 | Second Faculty of Medicine
- Bimekizumab v léčbě psoriázy2022 | First Faculty of Medicine
